logo

For the Inventor, By the Inventor

Syracuse, NY, United States of America

Jonathan L Miller

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignee: The State University of New York. Active years: 1994-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan L Miller. Retrieved from https://idiyas.com/inventor/jonathan-l-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 90.0

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 77(Granted Patents)


Company Filing History:

goldMedal10 out of 2,044 
 
The State University of New York
 patents

Years Active: 1994-2009

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7544774 - Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX (2009-06-09),
2. 7112661 - Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha (2006-09-26),
3. 7074888 - Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX (2006-07-11),
4. 5877155 - Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX (1999-03-02),
5. 5817748 - Mimotopes of human Platelet glycoprotein Ib/IX (1998-10-06),
6. 5624817 - Mutations in the gene encoding the alpha chain of platelet glycoprotein (1997-04-29),
7. 5593959 - Mutations in the gene encoding the alpha chain of platelet glycoprotein (1997-01-14),
8. 5492809 - Mutations rendering platelet glycoprotein Ib-.alpha. less reactive (1996-02-20),
9. 5317097 - Mutations in the gene encoding the .alpha. chain on platelet (1994-05-31),
10. 5298239 - Mutations rendering platelet glycoprotein IB .alpha. less reactive (1994-03-29),

Title: Innovations of Jonathan L Miller

Introduction

Jonathan L Miller is a prominent inventor based in Syracuse, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of platelet glycoproteins. With a total of 10 patents to his name, Miller's work has the potential to impact medical treatments and therapies.

Latest Patents

Miller's latest patents include groundbreaking inventions such as "Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX." This invention focuses on an isolated peptide that mimics a binding site for a monoclonal antibody, which recognizes an epitope within the human platelet glycoprotein Ib/IX complex. Additionally, he has developed methods for selecting clones that bind to human platelet glycoprotein Ib alpha, which can inhibit platelet aggregation. These innovations also encompass isolated nucleic acid molecules and expression vectors that facilitate the production of antibodies targeting human platelet glycoprotein Ib alpha.

Career Highlights

Miller is affiliated with the State University of New York, where he conducts research and develops his inventions. His work has garnered attention for its potential applications in medical science, particularly in improving treatments for conditions related to platelet function.

Collaborations

Some of Miller's notable coworkers include Vicki A Lyle and David Cunningham. Their collaborative efforts contribute to the advancement of research in the field of platelet glycoproteins.

Conclusion

Jonathan L Miller's innovative work in the realm of platelet glycoproteins showcases his dedication to advancing medical science. His patents reflect a commitment to developing solutions that could significantly enhance patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…